2022 has begun with dismal news for investors in SillaJen, Inc. as the Korea Exchange has made a preliminary decision to delist the South Korean biotech’s stock from its Kosdaq bourse after a 12-month period for corporate reforms ended late last year.
The exchange reportedly made the decision as the company has failed to meet some of operational issues and the decision...







